Ivacaftor

Specifications

873054-44-5CAS Number

800-027-5EC Number

N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamideIUPAC Name

C24H28N2O3Chemical Formula

392.5 g/molMolecular Weight

Ivacaftor; 873054-44-5; VX-770; Kalydeco; N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide; ivacaftorum; 1Y740ILL1Z; CHEBI:66901; DTXSID00236281; ORKAMBI COMPONENT IVACAFTOR; SYMKEVI COMPONENT IVACAFTOR; TRIKAFTA COMPONENT IVACAFTOR; 3-Quinolinecarboxamide, N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-; 3-Quinolinecarboxamide, N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-1,4-dihydro-4-oxo-; N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide; N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide; RefChem:58494; DTXCID00158772; R07AX02; Elexacaftor, Tezacaftor, and Ivacaftor; 800-027-5; Ivacaftor (VX-770); N-[2,4-Bis(tert-butyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide; Ivacaftor-d18; VX 770; 1413431-05-6; MFCD17171361; N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide; s1144; Ivacaftor (4-tertbutyl-d9) (Major); Kalydeco (TN); Ivacaftor [USAN]; Ivacaftor [USAN:INN]; UNII-1Y740ILL1Z; VX7; IVACAFTOR [INN]; IVACAFTOR [MI]; Ivacaftor (USAN/INN); IVACAFTOR [VANDF]; IVACAFTOR [WHO-DD]; MLS006011119; SCHEMBL351373; SCHEMBL417309; GTPL4342; orb1223783; orb1305294; IVACAFTOR [ORANGE BOOK]; VX-770, Ivacaftor, Kalydeco; CHEMBL2010601; SCHEMBL29357389; SCHEMBL29379239; EX-A441; PURKAOJPTOLRMP-UHFFFAOYSA-N; HMS3654E10; HMS3744K05; HMS5079A11; NGC43107; BDBM50032693; EBC-11412; AKOS015994762; AKOS032950001; N-(2,4-ditert-butyl-5-hydroxy-phenyl)-4-oxo-1H-quinoline-3-carboxamide; CCG-268562; CS-0497; DB08820; EX-7211; LE-0002; SB16815; compound 48 [PMID: 25441013]; NCGC00242480-01; NCGC00242480-03; NCGC00242480-05; NCGC00242480-08; AC-28324; DA-54489; FI143182; HY-13017; SMR004702900; SY067891; NS00009974; SW219620-1; D09916; AB01565806_02; EN300-7400944; F468426; Q6095693; BRD-K52818472-001-02-2; Z2146566713; Cystic Fibrosis Transmembrane Conductance Regulator Potentiator; N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide; N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide; N-(5-Hydroxy-2,4-bis(2-methyl-2-propanyl)phenyl]-4-oxo-1,4-dihydro-3-quinolinecarboxamide; N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide; 1134822-00-6Synonyms